| E-Y0001257 |
EP |
【左乙拉西坦雜質(zhì)D（ |
Levetiracetam impurity D |
|
15 mg |
1264 |
28 |
| E-Y0001256 |
EP |
【左乙拉西坦雜質(zhì)C（ |
Levetiracetam impurity C |
|
15 mg |
1264 |
28 |
| E-Y0001255 |
EP |
【左乙拉西坦雜質(zhì)B（ |
Levetiracetam impurity B |
|
15 mg |
1264 |
28 |
| E-Y0001254 |
EP |
【左乙拉西坦雜質(zhì)A（ |
Levetiracetam impurity A |
|
10 mg |
1264 |
28 |
| E-Y0001253 |
EP |
【左乙拉西坦（訂貨以 |
Levetiracetam |
|
110 mg |
1264 |
28 |
| E-Y0001252 |
EP |
【美洛培南三水合物 |
Meropenem trihydrate |
|
110 mg |
1264 |
28 |
| E-Y0001251 |
EP |
【酚妥拉明系統(tǒng)適應(yīng) |
Phentolamine for system suitability |
|
10 mg |
1264 |
28 |
| E-Y0001250 |
EP |
【恩他卡朋雜質(zhì)A（訂 |
Entacapone impurity A |
|
10 mg |
1264 |
28 |
| E-Y0001249 |
EP |
【恩他卡朋（訂貨以英 |
Entacapone |
|
160 mg |
1264 |
28 |
| E-Y0001248 |
EP |
【托品酰胺雜質(zhì)D（訂 |
Tropicamide impurity D (Phenylacetic acid -*Drug Precursor) |
|
10 mg |
1264 |
28 |
| E-Y0001247 |
EP |
【托品酰胺雜質(zhì)C（訂 |
Tropicamide impurity C |
|
10 mg |
1264 |
28 |
| E-Y0001246 |
EP |
【硫唑嘌呤雜質(zhì)G（訂 |
Azathioprine impurity G |
|
5 mg |
1264 |
28 |
| E-Y0001245 |
EP |
【戊間甲酚峰值鑒別 |
Amylmetacresol for peak identification |
|
10 mg |
1264 |
28 |
| E-Y0001244 |
EP |
【戊間甲酚（訂貨以英 |
Amylmetacresol |
|
285 mg |
1264 |
28 |
| E-Y0001243 |
EP |
【葉酸雜質(zhì)D（訂貨以 |
Folic acid impurity D |
|
70 mg |
1264 |
28 |
粵公網(wǎng)安備 44010302000979號
